4D Paths Physics-Inspired QPOR Platform Predicts Neoadjuvant Chemotherapy Response from Routine Biopsy Images in Early-Stage Triple-Negative Breast Cancer from Phase II TBCRC-030 Trial
NEWTON, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- 4D Path, a company…
Avalara Predicts 2026 Will Reshape Global Business Through AI, Transparency, and Compliance Agility
New Avalara insights forecast how automation, regulation, and real-time data will impact…
